Cho et al., 2021 - Google Patents
Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancerCho et al., 2021
View HTML- Document ID
- 4581437363396983313
- Author
- Cho J
- Sim M
- Kim S
- Kim K
- Lee T
- Lee J
- Kang W
- Kim S
- Publication year
- Publication venue
- Journal of Cancer Research and Therapeutics
External Links
Snippet
Background: The aims of this study were to detect circulating tumor cells (CTCs) at the single- cell level in cerebrospinal fluid (CSF) and to identify intrapatient heterogeneity of CTCs in a patient with gastric cancer (GC) with leptomeningeal metastasis (LM) using Di-Electro …
- 208000005443 Circulating Neoplastic Cells 0 title abstract description 61
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Domínguez-Vigil et al. | The dawn of the liquid biopsy in the fight against cancer | |
Zhang et al. | Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer | |
Witkowski et al. | Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type | |
Park et al. | Molecular profiling of single circulating tumor cells from lung cancer patients | |
van den Bosch et al. | Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis | |
Li et al. | Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases | |
Ilie et al. | Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine? | |
Pardanani et al. | FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia | |
Alva et al. | Circulating tumor cells as potential biomarkers in bladder cancer | |
Park et al. | Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype | |
Campos et al. | Molecular profiling of liquid biopsy samples for precision medicine | |
Decaussin‐Petrucci et al. | Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy | |
Mino-Kenudson | Cons: Can liquid biopsy replace tissue biopsy?—the US experience | |
Huang et al. | Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis | |
Müller et al. | Concordance between comprehensive cancer genome profiling in plasma and tumor specimens | |
Qiu et al. | Circulating tumor cells correlate with clinicopathological features and outcomes in differentiated thyroid cancer | |
US20220162706A1 (en) | Intra-patient genomic heterogeneity of single circulating tumor cells (ctcs) associated to phenotypic ctc heterogeneity in metastatic castrate resistant prostate cancer (mcrpc) | |
Ross et al. | The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer | |
Bonnet et al. | Simplified identification of Lynch syndrome: a prospective, multicenter study | |
Bartsch et al. | The German National Case Collection for Familial Pancreatic Cancer (FaPaCa): Knowledge Gained in 20 Years | |
EP3376227B1 (en) | Methods for diagnosing and treating cancer | |
Zieren et al. | Diagnostic liquid biopsy biomarkers in renal cell cancer | |
Cho et al. | Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer | |
Capaldi et al. | Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma | |
Sharma et al. | An evaluation of a fluorescence in situ hybridization strategy using air-dried blood and bone-marrow smears in the risk stratification of pediatric B-lineage acute lymphoblastic leukemia in resource-limited settings |